Hypostamine or tritoqualine
- Level
- Commodity
- Parent
- 51314200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51314201This classification denotes a cholagogue, choleretic, histamine h1 antagonist, and phthalic anhydride with the molecular formula C26H32N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F4MW5166YH, chemically known as 4,5,6-triethoxy-7-amino-3-(8-methoxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydro-1-isochinolinyl)phthalid but generally known as tritoqualine, which bears US NIH Compound Identifier 72145. European Medicines Agency schedules Tritoqualine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11326MIG. World Health Organization schedules tritoqualine in its Anatomical Therapeutic Chemical (ATC) Classification. TRITOQUALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Hypostamine or tritoqualine bears US NLM identifiers UMLS ID C0077316 and NCI Concept Code C97409. SMILES: O1C(C2N(CCC3C2C(OC)C2OCOC2C3)C)C2C(C1=O)C(N)C(OCC)C(OCC)C2OCC.
Same parent
Under 51314200 · 3Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.